80 Participants Needed

Happy Bob App for Type 1 Diabetes

SM
Overseen BySophie MacColl
Age: < 18
Sex: Any
Trial Phase: Academic
Sponsor: Children's Mercy Hospital Kansas City
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Do I have to stop taking my current medications for this trial?

The trial protocol does not specify whether you need to stop taking your current medications. It seems likely that you can continue your current treatment, as the trial focuses on using an app for support.

Do I need to stop my current medications for the trial?

The trial information does not specify whether you need to stop taking your current medications. It seems likely that you can continue your usual diabetes treatment while using the app, but it's best to confirm with the trial organizers.

What data supports the idea that Happy Bob App for Type 1 Diabetes is an effective treatment?

The available research does not provide specific data on the effectiveness of the Happy Bob App for Type 1 Diabetes. However, it mentions other treatments like the Diabeo software and closed-loop control systems, which have shown improvements in managing diabetes. For example, the Diabeo software, combined with telemedicine support, improved blood sugar control in patients. This suggests that technology-based treatments can be effective, but specific data on the Happy Bob App is not available in the provided information.12345

What data supports the effectiveness of the Happy Bob App treatment for Type 1 Diabetes?

Research shows that using technology, like apps and software, can help people with type 1 diabetes manage their condition better. For example, the Diabeo software, which helps adjust insulin doses, improved blood sugar control in patients. This suggests that similar apps, like Happy Bob, might also be effective.12345

What safety data exists for the Happy Bob App for Type 1 Diabetes?

The provided research does not contain specific safety data for the Happy Bob App or any treatment under the name Happy Bob. The studies focus on closed-loop control systems, do-it-yourself artificial pancreas systems, and educational tools for diabetes management, but none mention the Happy Bob App directly. Therefore, no safety data for the Happy Bob App is available in the provided research.26789

Is the Happy Bob App a promising treatment for Type 1 Diabetes?

The Happy Bob App is a promising treatment for Type 1 Diabetes because it offers a new way to help people manage their condition. It uses technology to make it easier for patients to monitor their blood sugar levels and manage their insulin, which can improve their daily lives.810111213

How does the Happy Bob App treatment for Type 1 Diabetes differ from other treatments?

The Happy Bob App is unique because it likely integrates technology to assist in managing Type 1 Diabetes, potentially offering a novel approach compared to traditional insulin delivery systems. While other treatments focus on automated insulin delivery, this app may provide additional support or motivation through its interface, making diabetes management more engaging and personalized.710111213

What is the purpose of this trial?

The goal of this clinical trial is to evaluate the impact of peer support via the Happy Bob phone app in youth with Type 1 Diabetes.The main questions it aims to answer are: What is the usability and acceptability of the app? What is the app's efficacy on measures such as treatment adherence and social support? And how are these effects impacted by remote patient monitoring by clinic staff?Participants will use the Happy Bob app for 6 months and will complete a series of surveys at the start, middle, and end of their use of the app. Some participants will participate in 2 remote patient monitoring sessions when beginning their use of the app.

Eligibility Criteria

This trial is for young people with Type 1 Diabetes who use a Dexcom device and a smartphone. It's designed to see if the Happy Bob app helps them manage their diabetes by providing peer support and monitoring.

Inclusion Criteria

I have Type 1 Diabetes and use a Dexcom with a smartphone.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants use the Happy Bob app and complete surveys at the start, middle, and end of the 6-month period

6 months
3 survey completions (start, middle, end), 2 remote monitoring sessions for some participants

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

Treatment Details

Interventions

  • Happy Bob App
Trial Overview The study tests the Happy Bob app, focusing on its user-friendliness, how well it's liked, and its effectiveness in improving treatment adherence and social support over six months, including some remote patient monitoring sessions.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: RPM (remote patient monitoring)Experimental Treatment2 Interventions
Group II: Non-RPMActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Children's Mercy Hospital Kansas City

Lead Sponsor

Trials
261
Recruited
941,000+

Findings from Research

A pilot trial involving six patients with type 1 diabetes demonstrated that a computer model could effectively simulate blood glucose levels based on self-reported data, helping to suggest alternative insulin doses and meal sizes to minimize the risk of hypo- and hyperglycemia.
Participants found the system helpful, but challenges with data entry limited its usage, indicating that user experience improvements are needed for better implementation in future studies.
Use of the Internet to optimize self-management of type 1 diabetes: preliminary experience with DiasNet.Cavan, DA., Everett, J., Plougmann, S., et al.[2007]
A study involving 43 children and adolescents with type 1 diabetes showed that after participating in a virtual educational camp and using the Control-IQ closed-loop control system, there were significant improvements in positive emotions, with 67% reporting increased positive feelings immediately and 65% six months later.
The use of the Control-IQ system also led to a notable increase in time in range (TIR) for blood glucose levels, rising from 64% to 75% over six months, indicating improved glucose management in these patients.
Significant and persistent improvements in time in range and positive emotions in children and adolescents with type 1 diabetes using a closed-loop control system after attending a virtual educational camp.Rabbone, I., Savastio, S., Pigniatiello, C., et al.[2022]
The Diabeo software, which allows for personalized insulin dose adjustments and includes telemedicine support, significantly reduced HbA1c levels in poorly controlled type 1 diabetes patients, achieving a mean HbA1c of 8.41% compared to 9.10% in the usual care group.
Patients using the Diabeo system experienced a 0.91% improvement in HbA1c over controls without an increase in hypoglycemic episodes or additional medical time, making it a cost-effective option for managing diabetes.
The Diabeo software enabling individualized insulin dose adjustments combined with telemedicine support improves HbA1c in poorly controlled type 1 diabetic patients: a 6-month, randomized, open-label, parallel-group, multicenter trial (TeleDiab 1 Study).Charpentier, G., Benhamou, PY., Dardari, D., et al.[2022]

References

Use of the Internet to optimize self-management of type 1 diabetes: preliminary experience with DiasNet. [2007]
Significant and persistent improvements in time in range and positive emotions in children and adolescents with type 1 diabetes using a closed-loop control system after attending a virtual educational camp. [2022]
The Diabeo software enabling individualized insulin dose adjustments combined with telemedicine support improves HbA1c in poorly controlled type 1 diabetic patients: a 6-month, randomized, open-label, parallel-group, multicenter trial (TeleDiab 1 Study). [2022]
Role of Mobile Technology to Improve Diabetes Care in Adults with Type 1 Diabetes: The Remote-T1D Study iBGStar&#174; in Type 1 Diabetes Management. [2020]
Effectiveness of a closed-loop control system and a virtual educational camp for children and adolescents with type 1 diabetes: A prospective, multicentre, real-life study. [2021]
The Do-It-Yourself Artificial Pancreas: A Comprehensive Review. [2021]
Pre-school and school-aged children benefit from the switch from a sensor-augmented pump to an AndroidAPS hybrid closed loop: A retrospective analysis. [2022]
New-Onset Diabetes Educator to Educate Children and Their Caregivers About Diabetes at the Time of Diagnosis: Usability Study. [2023]
Hybrid Closed Loop Using a Do-It-Yourself Artificial Pancreas System in Adults With Type 1 Diabetes. [2023]
10.United Statespubmed.ncbi.nlm.nih.gov
Do-It-Yourself (DIY) Artificial Pancreas Systems for Type 1 Diabetes: Perspectives of Two Adult Users, Parent of a User and Healthcare Professionals. [2021]
11.United Statespubmed.ncbi.nlm.nih.gov
Feasibility and Preliminary Safety of Smartphone-Based Automated Insulin Delivery in Adolescents and Children With Type 1 Diabetes. [2022]
12.United Statespubmed.ncbi.nlm.nih.gov
First Use of Open-Source Automated Insulin Delivery AndroidAPS in Full Closed-Loop Scenario: Pancreas4ALL Randomized Pilot Study. [2023]
Telecare for teenagers with type 1 diabetes: a trial. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security